Search

everythinglearnresearchcommunity

for

Search:↓

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Young men's erectile dysfunction is linked to mental health issues and risky behaviors promoted by online communities, highlighting the need for better mental health support and healthy masculinity standards.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

Trichoscopy is a quick, cost-effective tool for diagnosing different hair loss conditions.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

AI in medicine raises many questions and concerns.

Extracellular vesicles could offer precise treatments for psychiatric conditions by targeting brain networks.

COVID-19 is linked to temporary hair loss, especially in women.

Training programs are needed to improve home COVID-19 management in Mangalore.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Elderly patients frequently suffer from skin conditions, especially inflammatory ones, highlighting the need for better healthcare.

Regenerative medicine in Malaysia shows promise for treating diseases but faces ethical and safety challenges.

Pregnancy skin issues can lead to complications, seborrheic dermatitis is linked to STDs, community education helps homeless women's skin, topical timolol is safe for infant hemangiomas, synthetic progestins affect melasma risk, and hijab-related hair loss affects mental health, with cultural barriers limiting treatment access.

Early treatment of COVID-19-related hair loss is crucial for better outcomes.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.

Early detection and prevention of suicide risk in teens is crucial, involving healthcare awareness, family support, and cross-sector collaboration.

Alternative therapies for men's health lack strong scientific support and need more research.

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

AI-personalized hair loss treatments improved hair growth and scalp health without side effects.